Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Hurt, D.E., Sutton, A.E., Clardy, J.(2006) Bioorg.Med.Chem.Lett. 16: 1610-1615
- PubMed: 16406782 
- DOI: 10.1016/j.bmcl.2005.12.029
- PubMed Abstract: 
Therapeutic agents brequinar sodium and leflunomide (Arava) work by binding in a hydrophobic tunnel formed by a highly variable N-terminus of family 2 dihydroorotate dehydrogenase (DHODH). The X-ray crystallographic structure of an analog of brequina ...